Science Explorer Back to mapMap
Discussion
Company · Boston · United States

Paratek Pharmaceuticals (United States)

Research works
107
▼ 37% vs 2018-21
Citations
2.7k
25.5 per fractional work
Top-10% rate
5.8%
all institutions 10.0%
Open access
55%
world 40%
International
17%
world 18%

Not ranked overall: Paratek Pharmaceuticals (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Paratek Pharmaceuticals (United States) work in?

In all years, 41% of research at Paratek Pharmaceuticals (United States) is in Health Sciences, 31% in Life Sciences. Its largest fields are Medicine (40%), Biochemistry, Genetics and Molecular Biology (21%), Engineering (16%). It does 1.9× the world's share of Life Sciences.

Health Sciences: 44 fractional works · 41.1% of its workMedicine: 43 fractional works · 39.7% of its workInfectious Diseases: 11 fractional works · 10.1% of its workPharmacology: 10 fractional works · 9.2% of its workEpidemiology: 8 fractional works · 7.9% of its workPublic Health, Environmental and Occupational Health: 2 fractional works · 2.2% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 1.3% of its workUrology: 1 fractional works · 1.3% of its workDermatology: 1 fractional works · 1.1% of its workOncology: 1 fractional works · 1.0% of its workSurgery: 1 fractional works · 0.8% of its workPulmonary and Respiratory Medicine: 1 fractional works · 0.7% of its workGenetics: 1 fractional works · 0.6% of its workPsychiatry and Mental health: 1 fractional works · 0.6% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 0.5% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 0.5% of its workPhysiology: 0 fractional works · 0.4% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 0.3% of its workReproductive Medicine: 0 fractional works · 0.3% of its workEmergency Medicine: 0 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 0.6% of its workDentistry: 1 fractional works · 0.7% of its workPeriodontics: 1 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.1% of its workVeterinary: 0 fractional works · 0.4% of its workSmall Animals: 0 fractional works · 0.4% of its workHealth Professions: 0 fractional works · 0.2% of its workGeneral Health Professions: 0 fractional works · 0.2% of its workNursing: 0 fractional works · 0.1% of its workLife Sciences: 34 fractional works · 31.4% of its workBiochemistry, Genetics and Molecular Biology: 22 fractional works · 20.6% of its workMolecular Medicine: 10 fractional works · 9.7% of its workMolecular Biology: 6 fractional works · 5.3% of its workGenetics: 2 fractional works · 1.7% of its workBiotechnology: 2 fractional works · 1.7% of its workClinical Biochemistry: 1 fractional works · 1.3% of its workEndocrinology: 1 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.3% of its workImmunology and Microbiology: 9 fractional works · 8.3% of its workApplied Microbiology and Biotechnology: 6 fractional works · 6.0% of its workImmunology: 1 fractional works · 1.3% of its workMicrobiology: 1 fractional works · 1.0% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 1.3% of its workPharmacology: 1 fractional works · 1.3% of its workAgricultural and Biological Sciences: 1 fractional works · 0.9% of its workFood Science: 0 fractional works · 0.4% of its workPlant Science: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workNeuroscience: 0 fractional works · 0.3% of its workNeurology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPhysical Sciences: 28 fractional works · 26.0% of its workEngineering: 17 fractional works · 15.8% of its workElectrical and Electronic Engineering: 8 fractional works · 7.7% of its workAerospace Engineering: 4 fractional works · 3.8% of its workBiomedical Engineering: 4 fractional works · 3.4% of its workMechanical Engineering: 1 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.3% of its workChemistry: 4 fractional works · 3.5% of its workOrganic Chemistry: 3 fractional works · 2.6% of its workAnalytical Chemistry: 1 fractional works · 0.6% of its workSpectroscopy: 0 fractional works · 0.3% of its workMaterials Science: 3 fractional works · 2.8% of its workMaterials Chemistry: 2 fractional works · 1.6% of its workGeneral Materials Science: 0 fractional works · 0.4% of its workBiomaterials: 0 fractional works · 0.3% of its workElectronic, Optical and Magnetic Materials: 0 fractional works · 0.2% of its workCeramics and Composites: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workComputer Science: 2 fractional works · 1.8% of its workComputational Theory and Mathematics: 1 fractional works · 1.4% of its workArtificial Intelligence: 0 fractional works · 0.5% of its workEnvironmental Science: 2 fractional works · 1.7% of its workPollution: 1 fractional works · 1.1% of its workEcology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.4% of its workMathematics: 0 fractional works · 0.2% of its workPhysics and Astronomy: 0 fractional works · 0.1% of its workSocial Sciences: 2 fractional works · 1.5% of its workArts and Humanities: 1 fractional works · 0.8% of its workHistory and Philosophy of Science: 1 fractional works · 0.6% of its workArcheology: 0 fractional works · 0.2% of its workSocial Sciences: 0 fractional works · 0.4% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.3% of its workEconomics and Econometrics: 0 fractional works · 0.3% of its workALL ITS WORKParatekPharmaceuticals…107fractional works, all years
Life Sciences31%Physical Sciences26%Health Sciences41%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 20 fields, with their numbers
    1. Medicine4339.7%
    2. Dentistry10.7%
    3. Veterinary00.4%
    4. Health Professions00.2%
    5. Nursing00.1%
    1. Biochemistry, Genetics and Molecular Biology2220.6%
    2. Immunology and Microbiology98.3%
    3. Pharmacology, Toxicology and Pharmaceutics11.3%
    4. Agricultural and Biological Sciences10.9%
    5. Neuroscience00.3%
    1. Engineering1715.8%
    2. Chemistry43.5%
    3. Materials Science32.8%
    4. Computer Science21.8%
    5. Environmental Science21.7%
    6. Mathematics00.2%
    7. Physics and Astronomy00.1%
    1. Arts and Humanities10.8%
    2. Social Sciences00.4%
    3. Economics, Econometrics and Finance00.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.19× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.45× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 12.26× its world share, 2 worksImmunology and Micro…Neuroscience: 0.15× its world share, 0 worksNeuroscienceChemistry: 1.69× its world share, 0 worksChemistryEnvironmental Science: 0.18× its world share, 0 worksEnvironmental ScienceDentistry: 8.49× its world share, 1 worksDentistryMedicine: 3.06× its world share, 11 worksMedicineVeterinary: 11.91× its world share, 0 worksVeterinary1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 12.3×. Every wedge is a field page.

All 9 fields, with their numbers
  1. Immunology and Microbiology12.26×2 works
  2. Veterinary11.91×0 works
  3. Dentistry8.49×1 works
  4. Biochemistry, Genetics and Molecular Biology3.45×4 works
  5. Medicine3.06×11 works
  6. Chemistry1.69×0 works
  7. Agricultural and Biological Sciences0.19×0 works
  8. Environmental Science0.18×0 works
  9. Neuroscience0.15×0 works

Who are the top researchers at Paratek Pharmaceuticals (United States)?

Ranked on the quality score, Stephen A. Villano, Judith N. Steenbergen and Mark L. Nelson lead among researchers whose main affiliation is Paratek Pharmaceuticals (United States).

  1. 1 Stephen A. Villano United States · #144,620 worldwide 4.8k citations · 62 works
  2. 2 Judith N. Steenbergen United States · #225,891 worldwide 5.8k citations · 83 works
  3. 3 Mark L. Nelson United States · #646,079 worldwide 2.6k citations · 50 works
  4. 4 Amy L. Manley United States · #702,889 worldwide 1.4k citations · 33 works
  5. 5 Evan L. Tzanis United States · #872,075 worldwide 3.9k citations · 91 works
  6. 6 Paul C. McGovern United States · #1,201,807 worldwide 2.4k citations · 65 works
  7. 7 Lynne K. Garrity-Ryan United States · #1,260,419 worldwide 1.4k citations · 27 works
  8. 8 Jessica V. Pierce United States · #1,271,905 worldwide 883 citations · 26 works
  9. 9 Alisa W. Serio United States · #1,839,314 worldwide 2.8k citations · 64 works
  10. 10 Daniel H. Deck United States · #2,180,320 worldwide 270 citations · 23 works
All ranked researchers at Paratek Pharmaceuticals (United States)

What are the most cited papers from Paratek Pharmaceuticals (United States)?

The most cited paper from Paratek Pharmaceuticals (United States) is "The history of the tetracyclines" (Mark L. Nelson, Stuart B. Levy, 2011), with 474 citations. Next come "The crystal structure of MarR, a regulator of multiple antibiotic resistance, at 2.3 A resolution." (389) and "Omadacycline for Community-Acquired Bacterial Pneumonia" (236).

Most cited papers
#PaperReleasedCitations
1 The history of the tetracyclines Mark L. Nelson, Stuart B. Levy · Annals of the New York Academy of Sciences Dec 2011 474
2 The crystal structure of MarR, a regulator of multiple antibiotic resistance, at 2.3 A resolution. Michael N. Alekshun, Stuart B. Levy, Tanya R. Mealy et al. · Nature Structural Biology Aug 2001 389
3 Omadacycline for Community-Acquired Bacterial Pneumonia Roman Stets, Monica Popescu, Joven Gonong et al. · New England Journal of Medicine Open access 6 Feb 2019 236
4 Breakthrough advances in low loss, tunable dielectric materials L. C. Sengupta, Somnath Sengupta · Materials Research Innovations Apr 1999 197
5 In Vitro and In Vivo Antibacterial Activities of Omadacycline, a Novel Aminomethylcycline Ann B. Macone, B. K. Caruso, Raina G. Leahy et al. · Antimicrobial Agents and Chemotherapy Open access 3 Dec 2013 170
All 61 most cited papers, with filters and sorting

Which keywords describe research at Paratek Pharmaceuticals (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Antibiotic Resistance, Antimicrobial Resistance, ESKAPE Pathogens, Multidrug-Resistant Bacteria, Virulence Factors, Healthcare-Associated Infections and Drug Resistance.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology29▲ 6.8×22 topics
  2. Antibiotic Resistance21▲ 48×7 topics
  3. Antimicrobial Resistance20▲ 74×6 topics
  4. ESKAPE Pathogens10▲ 184×1 topic
  5. Multidrug-Resistant Bacteria10▲ 184×1 topic
  6. Virulence Factors9▲ 44×3 topics
  7. Healthcare-Associated Infections9▲ 68×3 topics
  8. Drug Resistance8▲ 25×3 topics
  9. Public Health8▲ 5.7×5 topics
  10. Antibiotic Pharmacokinetics8▲ 169×1 topic
  11. Critically Ill Patients8▲ 169×1 topic
  12. Clinical Management7▲ 33×5 topics
  13. Infectious Diseases7▲ 28×3 topics
  14. Clinical Practice Guidelines7▲ 11×4 topics
  15. Staphylococcus aureus7▲ 81×2 topics
  16. Antimicrobial Stewardship6▲ 204×1 topic
  17. Genetic Analysis6▲ 122×1 topic
  18. Global Health6▲ 46×1 topic
  19. MRSA6▲ 171×1 topic
  20. Treatment6▲ 4.0×7 topics
  21. Pathogenesis5▲ 7.7×8 topics
  22. Community-Acquired Pneumonia4▲ 102×1 topic
  23. Diagnosis4▲ 4.1×5 topics
  24. Pneumococcal Conjugate Vaccine4▲ 102×1 topic
  25. Microwave Filters4▲ 50×1 topic
  26. Substrate Integrated Waveguide4▲ 50×1 topic
  27. Drug Discovery3▲ 7.3×4 topics
  28. Antibiotics3▲ 33×3 topics
  29. Secondary Metabolites3▲ 27×2 topics
  30. Immune Response3▲ 4.2×6 topics
  31. Toxins3▲ 22×2 topics
  32. Pharmacokinetics2▲ 8.5×4 topics
  33. Acoustic Wave Biosensors2▲ 45×1 topic
  34. Thin Film Resonators2▲ 45×1 topic
  35. Vaccine2▲ 5.4×3 topics
  36. Antibiotic-Associated Diarrhea2▲ 71×1 topic
  37. Fecal Microbiota Transplantation2▲ 71×1 topic
  38. Photodynamic Therapy2▲ 12×4 topics
  39. Genomic Studies2▲ 21×2 topics
  40. Mycobacterium tuberculosis2▲ 27×1 topic

Which research topics does Paratek Pharmaceuticals (United States) publish most on?

By volume in 2022-now: Antibiotic Resistance in Bacteria, Pneumonia and Respiratory Infections, Antibiotics Pharmacokinetics and Efficacy and Antibiotic Use and Resistance.

  1. 1 Antibiotic Resistance in Bacteria Molecular Medicine 2 works
  2. 2 Pneumonia and Respiratory Infections Epidemiology 2 works
  3. 3 Antibiotics Pharmacokinetics and Efficacy Pharmacology 2 works
  4. 4 Antibiotic Use and Resistance Applied Microbiology and Biotechnology 2 works
  5. 5 Mycobacterium research and diagnosis Epidemiology 2 works
  6. 6 Tuberculosis Research and Epidemiology Infectious Diseases 1 works
  7. 7 Antimicrobial Resistance in Staphylococcus Infectious Diseases 1 works
  8. 8 Streptococcal Infections and Treatments Public Health, Environmental and Occupational Health 1 works
  9. 9 Bacterial Identification and Susceptibility Testing Clinical Biochemistry 1 works
  10. 10 Clostridium difficile and Clostridium perfringens research Infectious Diseases 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available54.7%not open45.3%

World: 40% of research is openly available.

with international co-authors16.7%domestic only83.3%

World: 18% is written across borders.

How has Paratek Pharmaceuticals (United States)'s research output changed?

Output in 2022-2025 was 37% lower than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Paratek Pharmaceuticals (United States) as a percentage of every work published that year, 0.000047% in 2024.

still counting0.00020%0.00040%0.00060%Paratek Pharmaceuticals (United States)0.000087% in 2025200020102020

Fractional works of Paratek Pharmaceuticals (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Boston

All research institutions in Boston

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Paratek Pharmaceuticals (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.